|
業務類別
|
Biotechnology |
|
業務概覽
|
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT. |
| 公司地址
| 15 Crosby Drive, Bedford, MA, USA, 01730 |
| 電話號碼
| +1 781 357-4000 |
| 傳真號碼
| +1 781 275-7562 |
| 公司網頁
| https://www.ocutx.com |
| 員工數量
| 274 |
| Mr. Jason Shand Robins |
Interim Chief Financial Officer and Principal Accounting Officer |
-- |
23/01/2026 |
| Mr. David Wayne Robinson |
Global Chief Commercial Officer |
-- |
30/04/2026 |
| Dr. Nadia Waheed, M.D. |
Chief Medical Officer |
美元 536.67K |
30/04/2026 |
| Ms. Namrata Saroj |
Chief Business Officer |
-- |
30/04/2026 |
| Dr. Sanjay Nayak, M.B.B.S.,PhD |
Chief Strategy Officer |
美元 510.00K |
30/04/2026 |
| Dr. Pravin U. Dugel, M.D. |
Chairman of the Board, President and Chief Executive Officer |
美元 819.20K |
30/04/2026 |
| Mr. Donald Notman |
Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer |
美元 560.18K |
23/01/2026 |
| Mr. Todd Anderman |
Chief Legal Officer and Secretary |
-- |
30/04/2026 |
| Dr. Jeffrey S. Heier, M.D. |
Chief Scientific Officer |
-- |
30/04/2026 |
| Dr. Peter Kaiser, M.D. |
Chief Development Officer |
-- |
30/04/2026 |
|
|
| Dr. Richard L. Lindstrom,M.D. |
Independent Director |
30/04/2026 |
| Dr. Adrienne L. Graves,PhD |
Independent Director |
30/04/2026 |
| Dr. Seung Suh Hong, PhD |
Independent Director |
30/04/2026 |
| Ms. Leslie J. Williams |
Independent Director |
30/04/2026 |
| Dr. Pravin U. Dugel, M.D. |
Chairman of the Board, President and Chief Executive Officer |
30/04/2026 |
| Ms. Merilee Raines |
Independent Director |
30/04/2026 |
| Mr. Charles Warden |
Lead Independent Director |
30/04/2026 |
|
|
|
|
